Correlation Between Aerovate Therapeutics and Helio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Helio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Helio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Helio, you can compare the effects of market volatilities on Aerovate Therapeutics and Helio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Helio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Helio.

Diversification Opportunities for Aerovate Therapeutics and Helio

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Aerovate and Helio is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Helio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helio and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Helio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helio has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Helio go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Helio

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Helio. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 3.83 times less risky than Helio. The stock trades about -0.01 of its potential returns per unit of risk. The Helio is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  370.00  in Helio on October 22, 2024 and sell it today you would earn a total of  228.00  from holding Helio or generate 61.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Helio

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Helio 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Helio are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent technical and fundamental indicators, Helio displayed solid returns over the last few months and may actually be approaching a breakup point.

Aerovate Therapeutics and Helio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Helio

The main advantage of trading using opposite Aerovate Therapeutics and Helio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Helio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helio will offset losses from the drop in Helio's long position.
The idea behind Aerovate Therapeutics and Helio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.